Evidence map›Paper›PMID 30514762›Full record

ArticleThe Journal of biological chemistry2019

Reversible

Satoshi Hara, Soichiro Fukumura, Hiroshi Ichinose

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Satoshi HaraSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama 226-8501, Japan.
Soichiro FukumuraSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama 226-8501, Japan.
Hiroshi IchinoseSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama 226-8501, Japan. Electronic address: hichinos@bio.titech.ac.jp.
Tokyo Institute of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

6-Pyruvoyl tetrahydropterin synthase (PTS) converts 7,8-dihydroneopterin triphosphate into 6-pyruvoyltetrahydropterin and is a critical enzyme for the

Indexed as

Gene Expression Regulation, EnzymologicCysteineGlutathioneHeLa CellsHumansOxidation-ReductionOxidative StressPhosphorus-Oxygen LyasesProtective AgentsPterins6-pyruvoyltetrahydropterin synthaseCysteineGlutathionePhosphorus-Oxygen LyasesProtective AgentsPterinstetrahydropterin6-pyruvoyl tetrahydropterin synthaseglutathionylationimmune cellmacrophageneopterinoxidative stressredox regulationtetrahydrobiopterin (BH4)thiol

Identifiers

PMID30514762
PMCPMC6349096
OpenAlexW2903364236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.